What is more, in different types of cancer, overexpression and mutation of the epidermal growth factor receptor (EGFR) have been observed; thus, finding inhibitors of EGFR kinases among (thio)ureido-quinazoline derivatives is also a promising approach to tumor treatment [22,23]. Here, EGFR is linked to neoplasm.